Concepedia

Publication | Open Access

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer

DOIFull Paper Access

852

Citations

20

References

2017

Year

Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins,
JAMA

Abstract

clinicaltrials.gov identifier: NCT00265850.

References

YearCitations

Page 1